Thus, if all goes well — on the evening of Friday, June 10, 2016 (while I am away at a wedding) Ebola will be tamped out, in this last outbreak, in all of Africa. Here is a bit from the WHO release, overnight:
. . . .Liberia’s and Guinea’s last known Ebola patients in a latest flare-up of the disease that hit both countries have now been discharged. All remaining contacts of confirmed cases that were placed under a 3-week period of medical monitoring have been cleared.
Liberia’s Ministry of Health, WHO and partners involved in the response held a ceremony at the Ebola treatment facility in Monrovia to celebrate the recovery and discharge of a 2-year-old boy, the final patient in the flare-up in Liberia. His 5-year-old brother recovered a week earlier. On 29 April, the country also began a 42-day period of increased surveillance – amounting to two 21-day incubation cycles of the virus. . . .
To help contain the spread, 1500 contacts and contacts of theirs were vaccinated with an experimental Ebola vaccine. Providing the vaccine is part of an ongoing [Merck] drug trial, the outcome of which will inform its possible licensing for future use. . . .
So say thanks to modern science — for saving these latest two young boys’ lives — and those of potentially literally millions of others. This is exactly the sort of legacy to which I referred earlier this evening, in that most recent post. Exactly. Smile.